Drug
Onvansertib
Onvansertib: highest development phase Phase 2, developed by Cardiff Oncology. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Cardiff Oncology
Trials
| Drug | Phase | Indication |
|---|---|---|
| Onvansertib NCT06106308 | Phase 2 | Metastatic Colorectal Cancer |
Latest
No recent events.
Follow Onvansertib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.